The influence of atropine and atenolol on the cardiac haemodynamic effects of NG‐nitro‐l‐arginine methyl ester in conscious, Long Evans rats
Open Access
- 1 March 1992
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 105 (3) , 653-656
- https://doi.org/10.1111/j.1476-5381.1992.tb09034.x
Abstract
1 In the present study, the extent to which baroreflexes contribute to the cardiac effects of NG-nitro-l-arginine methyl ester (l-NAME) was assessed in conscious, Long Evans rats chronically instrumented with thoracic electromagnetic flow probes for the measurement of cardiac haemodynamics. 2 l-NAME (10 mg kg−1, i.v.) was administered in the absence (n = 6) and in the presence (n = 7) of atropine (1 mg kg−1) and atenolol (1 mg kg−1). 3 l-NAME caused a marked increase in mean arterial pressure and marked reductions in total peripheral conductance, cardiac output, heart rate, stroke volume, peak thoracic flow and the maximum rate of rise of aortic flow. 4 Administration of atropine, after the maximal bradycardic effect of l-NAME was established, restored the heart rate to resting levels. Concurrently, there was a reduction in stroke volume, such that cardiac output, although transiently elevated, did not show a sustained increase. No other variables were significantly affected by atropine. Additional administration of atenolol had no effect other than to cause a slight bradycardia, such that in the presence of atropine and atenolol, heart rate was not different from that in animals receiving atropine and atenolol before l-NAME. 5 In the presence of atropine and atenolol, l-NAME had similar pressor, vasoconstrictor and cardiac haemodynamic effects to those in untreated animals, although the bradycardia was significantly attenuated. However, there was still a significant reduction in heart rate following l-NAME in the presence of atropine and atenolol. 6 These results indicate that the major component of the bradycardia following l-NAME is indirect and mediated through an increase in vagal efferent activity. However, the substantial reduction in cardiac function caused by l-NAME is not dependent on the autonomic control of the heart but rather, may depend on the increase in afterload and/or a direct effect of l-NAME on the heart and/or its vasculature.Keywords
This publication has 23 references indexed in Scilit:
- Cardiocirculatory Responses to AII and AVP in Conscious RatsJournal of Cardiovascular Pharmacology, 1991
- Effects of Intravenous Endothelin on Hemodynamics and Cardiac Contractility in Conscious Milan Normotensive RatsJournal of Cardiovascular Pharmacology, 1991
- Regional and cardiac haemodynamic effects of NG‐nitro‐l‐arginine methyl ester in conscious, Long Evans ratsBritish Journal of Pharmacology, 1990
- Effects of endothelin-1 on cardiac output in conscious rats in the absence and presence off cardiac autonomie blockadeEuropean Journal of Pharmacology, 1990
- Control of regional blood flow by endothelium-derived nitric oxide.Hypertension, 1990
- Biosynthesis of nitric oxide from l-arginineBiochemical Pharmacology, 1989
- NG-methylarginine, and inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo?Biochemical and Biophysical Research Communications, 1989
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Vagal and sympathetic components of the heart rate range and gain of the baroreceptor-heart rate reflex in conscious ratsJournal of the Autonomic Nervous System, 1987
- Central hemodynamics in the developmental stage of spontaneous hypertension in the unanesthetized rat.Hypertension, 1979